Coherus Oncology, Inc. Stock Performance

Open $1.05	Prev. Close $1.05	Circuit Range N/A
Day Range $1.05 - $1.11	Year Range $0.98 - $2.61	Volume 1,81,961
Average Traded $1.08

Coherus Oncology, Inc. Share Price Today

As of 10 October 2026, Coherus Oncology, Inc.'s share price is $1.07. The stock opened at $1.05, compared to its previous close of $1.05. During today's trading session, Coherus Oncology, Inc.'s share price traded between $1.05 and $1.11, with an average price of $1.08. Over the past 52 weeks, the stock has recorded a high of $2.61 and a low of $0.98. In terms of performance, Coherus Oncology, Inc.'s share price has declined by 39.72% over the last six months and is down 35.93% on a year-on-year basis.

Coherus Oncology, Inc. Share Price Chart

$1.05$1.11

Coherus Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap $125.34M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.86	Revenue (TTM) $42.17B	Return On Equity (TTM) -217.19%
Profit Margin 398.43%	Debt to Equity 0.61	Quarterly Earnings Growth YoY 41.94%

Coherus Oncology, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$11.57	$12.75	$12.31	$14.31
Net Profit	-$35.53	-$37.64	-$38.33	-$20.63
Net Profit Margin	-307.09%	-295.22%	-311.37%	-144.16%
Income Change	N/A	-5.94%	-1.83%	46.18%

Coherus Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$211.04	$257.24	$26.39	$42.17
Net Profit	-$291.75	-$237.89	$28.51	$168.02
Net Profit Margin	-138.24%	-92.48%	108.03%	398.43%
Income Change	N/A	18.46%	111.98%	489.34%

About Coherus Oncology, Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Coherus Oncology, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$1.21	$1.07	-10.42%
Sep 2026	$1.35	$1.20	-18.09%
Aug 2026	$1.42	$1.47	+4.27%
Jul 2026	$1.42	$1.41	+0.72%
Jun 2026	$1.63	$1.40	-12.54%
May 2026	$1.76	$1.59	-10.14%
Apr 2026	$1.75	$1.77	+4.41%
Mar 2026	$1.64	$1.70	+1.49%
Feb 2026	$2.16	$1.68	-22.09%
Jan 2026	$1.40	$2.15	+51.41%
Dec 2025	$1.31	$1.42	+4.80%
Nov 2025	$1.69	$1.35	-18.86%

CHRS Share Price FAQs

What is Coherus Oncology, Inc. share price today?

Coherus Oncology, Inc. share price today is $1.07 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Coherus Oncology, Inc. stock?

The 52 week high of Coherus Oncology, Inc. stock is $2.61, while the 52 week low is $0.98 as of 10 Oct '26.

What is CHRS's market capitalisation today?

CHRS market capitalisation is $125.34M as of October 10, 2026, at 3:01 am IST.

What is CHRS's net income for the last quarter?

CHRS's net income for the last quarter is -20.63B USD.

What is the 5 year returns of CHRS?

The 5 year returns of CHRS is -93.61% as on 10 Oct '26.

What is the high & low stock price of CHRS today?

CHRS stock price hit a high of $1.11 and low of $1.05 as of 10 Oct '26.

Can I buy CHRS shares in India?

Yes. You can buy CHRS in India by opening an international trading account.